PMID: 9542949May 23, 1998Paper

Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection

Journal of Clinical Microbiology
G GernaM G Revello

Abstract

In 7 of 18 solid-organ transplant recipients with primary human cytomegalovirus (HCMV) infection, HCMV antigenemia levels were unexpectedly found to rise significantly (P = 0.018) during a mean time of 7.3 +/- 3.2 days after initiation of specific antiviral treatment, whereas corresponding levels of viremia dropped significantly (P = 0.043). Thus, shifting to an alternative antiviral drug based solely on increasing antigenemia levels is not justified in this group of patients.

References

Sep 1, 1992·The Journal of General Virology·J C FoxV C Emery
Apr 11, 1991·The New England Journal of Medicine·R H Rubin
Dec 1, 1988·Journal of Clinical Microbiology·W van der BijT H The

❮ Previous
Next ❯

Citations

Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·L Rasmussen
Nov 8, 2001·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·N Singh
Feb 25, 2009·Expert Opinion on Pharmacotherapy·Andreas SchreiberDetlef Michel
Oct 5, 2002·Clinical Microbiology Reviews·Maria Grazia Revello, Giuseppe Gerna
Dec 23, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·María de OñaErnesto Gómez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.